Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Zignol

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Plos One|August 14, 2008
Management of extensively drug-resistant tuberculosis in Peru: cure is possibleCesar A Bonilla, Aldo Crossa, Hector O Jave, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 19, 2019
Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis ComplexJeffrey A Tornheim, Angela M Starks, Timothy C Rodwell, et al.
Bulletin of the World Health Organization|February 12, 2013
Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factorsAlena Skrahina, Henadz Hurevich, Aksana Zalutskaya, et al.
Scientific Reports|December 17, 2017
Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national surveyElisa Tagliani, Mohamed Osman Hassan, Yacine Waberi, et al.
Clinical Microbiology Reviews|November 4, 2025
Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practiceH Manisha Yapa, Emily L-H MacLean, Nicolas A Menzies, et al.
Plos One|December 31, 2009
Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006Pushpa Malla, Elisabeth Eva Kanitz, Mohammad Akhtar, et al.
Plos Medicine|July 11, 2023
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling studyAllison Portnoy, Jean-Louis Arcand, Rebecca A Clark, et al.
Emerging Infectious Diseases|October 29, 2009
Mycobacterium tuberculosis genotype and case notification rates, rural Vietnam, 2003-2006Tran N Buu, Mai N T Huyen, Nguyen N T Lan, et al.
The European Respiratory Journal|January 22, 2021
Framework for the evaluation of new tests for tuberculosis infectionYohhei Hamada, Saskia den Boon, Daniela Maria Cirillo, et al.
BMJ Global Health|July 12, 2023
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countriesAllison Portnoy, Rebecca A Clark, Chathika K Weerasuriya, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Plos One|August 14, 2008
Management of extensively drug-resistant tuberculosis in Peru: cure is possibleCesar A Bonilla, Aldo Crossa, Hector O Jave, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 19, 2019
Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis ComplexJeffrey A Tornheim, Angela M Starks, Timothy C Rodwell, et al.
Bulletin of the World Health Organization|February 12, 2013
Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factorsAlena Skrahina, Henadz Hurevich, Aksana Zalutskaya, et al.
Scientific Reports|December 17, 2017
Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national surveyElisa Tagliani, Mohamed Osman Hassan, Yacine Waberi, et al.
Clinical Microbiology Reviews|November 4, 2025
Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practiceH Manisha Yapa, Emily L-H MacLean, Nicolas A Menzies, et al.
Plos One|December 31, 2009
Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006Pushpa Malla, Elisabeth Eva Kanitz, Mohammad Akhtar, et al.
Plos Medicine|July 11, 2023
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling studyAllison Portnoy, Jean-Louis Arcand, Rebecca A Clark, et al.
Emerging Infectious Diseases|October 29, 2009
Mycobacterium tuberculosis genotype and case notification rates, rural Vietnam, 2003-2006Tran N Buu, Mai N T Huyen, Nguyen N T Lan, et al.
The European Respiratory Journal|January 22, 2021
Framework for the evaluation of new tests for tuberculosis infectionYohhei Hamada, Saskia den Boon, Daniela Maria Cirillo, et al.
BMJ Global Health|July 12, 2023
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countriesAllison Portnoy, Rebecca A Clark, Chathika K Weerasuriya, et al.
Pageof 9